Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and Dexcom (DXCM)

Tipranks - Fri Apr 3, 4:34AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TransMedics Group (TMDX) and Dexcom (DXCM) with bullish sentiments.

End of Quarter Sale - 50% Off TipRanks

TransMedics Group (TMDX)

William Blair analyst Ryan Daniels maintained a Buy rating on TransMedics Group today. The company’s shares closed last Wednesday at $100.40.

According to TipRanks.com, Daniels is a 1-star analyst with an average return of -2.9% and a 34.1% success rate. Daniels covers the Healthcare sector, focusing on stocks such as Hinge Health, Inc. Class A, Lifestance Health Group, and Pediatrix Medical Group. ;'>

Currently, the analyst consensus on TransMedics Group is a Moderate Buy with an average price target of $160.30, a 57.4% upside from current levels. In a report issued on March 18, TipRanks – Anthropic also upgraded the stock to Buy with a $138.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Dexcom (DXCM)

TD Cowen analyst Josh Jennings maintained a Buy rating on Dexcom today and set a price target of $84.00. The company’s shares closed last Wednesday at $62.37, close to its 52-week low of $62.34.

According to TipRanks.com, Jennings is a 3-star analyst with an average return of 1.2% and a 42.6% success rate. Jennings covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Orchestra BioMed Holdings, and Edwards Lifesciences. ;'>

Currently, the analyst consensus on Dexcom is a Strong Buy with an average price target of $86.76, representing a 38.2% upside. In a report issued on March 25, TipRanks – xAI also upgraded the stock to Buy with a $75.00 price target.

Read More on TMDX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.